ArticlePharmaceutical research2013

Trastuzumab labeled to high specific activity with ¹¹¹In by conjugation to G4 PAMAM dendrimers derivatized with multiple DTPA chelators exhibits increased cytotoxic potency on HER2-positive breast cancer cells.

Conrad Chan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.